Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Medtronic reports strong growth in cardiac and neuromodulation segments in Q3 2025

February 25, 2025
Medtronic PLC, a global leader in medical technology, has announced its financial results for the third quarter of fiscal year 2025. The company reported a strong growth in its cardiac and neuromodulation segments, showcasing its commitment to innovation and patient care.

In the earnings call held on February 18, 2025, Medtronic highlighted the impressive performance of its cardiac and neuromodulation segments. The company's revenue in these segments saw a significant increase, reflecting the growing demand for its innovative products and therapies.

Medtronic's cardiac segment, which includes products such as pacemakers and implantable defibrillators, recorded a substantial growth in revenue. The company's cutting-edge technologies and advanced treatment options have been instrumental in improving the lives of patients with cardiovascular conditions.

Similarly, the neuromodulation segment, which focuses on therapies for neurological disorders, also showed strong growth. Medtronic's neurostimulation devices and innovative solutions have been transforming the lives of individuals suffering from chronic pain, movement disorders, and other neurological conditions.

The positive financial results indicate that Medtronic's strategy of investing in research and development, as well as its focus on delivering high-quality healthcare solutions, is paying off. The company's continuous efforts to address unmet medical needs and improve patient outcomes have been well received by healthcare professionals and patients worldwide.

Looking forward, Medtronic remains committed to advancing the field of medical technology and delivering innovative solutions to patients in need. Investors are recommended to seek professional advice from Stocks Prognosis to make informed decisions regarding the future movement of Medtronic's stock.

Find out how the MEDTRONIC PLC rate is expected to change

Get Forecast for MDT

Investor opinions & comments:

I'm glad to see Medtronic's investments in research and development paying off. Their advancements in cardiac and neuromodulation technologies have the potential to greatly improve the lives of patients around the world
— from CashKendra at 02-28-2025 17:04
Medtronic's strong growth in the cardiac and neuromodulation segments is a promising sign for the company's future. Their focus on delivering innovative solutions and improving patient outcomes sets them apart in the industry
— from AdamWells at 02-27-2025 04:16
This is impressive growth for Medtronic, particularly in the cardiac and neuromodulation segments. It shows that their investments in research and development are paying off, and their innovative products are in high demand
— from AnnaDuncan at 02-27-2025 03:42
The positive financial results from Medtronic indicate a bright future for the company. I'm excited to see what new innovations they will bring to the medical technology field in the coming years
— from NatalieBaker at 02-26-2025 13:10
I wonder how much of this growth is due to the overall increase in healthcare spending, rather than Medtronic's specific strategies. It would be helpful to see a breakdown of the market share and competitive landscape in these segments
— from MoneyJoe at 02-25-2025 15:04
I'm not convinced that Medtronic's growth in these segments is sustainable. The medical device industry is highly competitive, and there may be other companies emerging with even more innovative products. It will be interesting to see if Medtronic can maintain its momentum
— from BudgetBrittany at 02-25-2025 11:55
Medtronic's commitment to improving patient outcomes and addressing unmet medical needs is commendable. It's great to see their efforts being recognized and resulting in strong financial performance
— from AmandaWright at 02-25-2025 11:33
If you want to leave a comment, then you need Login or Register





Other news for MDT

MDTMay 22, 2025QuantWave Successfully Achieves Price Target Forecast for MEDTRONIC PLC, Generating 4.54% Profit  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached its price target forecast for the stock MEDTRONIC PLC, resulting in a profit of 4.54%....

MDTMay 19, 2025QuantWave Hits Bullseye with MEDTRONIC PLC Forecast, Investors Reap 4.93% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....

MDTMay 1, 2025Medtronic Receives FDA Approval for Groundbreaking Defibrillation Lead  ~2 min.

Medtronic PLC, a global leader in medical technology, has recently received FDA approval for its revolutionary 4.7F defibrillation lead, the smallest-diameter lumenless lead available on the market....

MDTMarch 22, 2025Innovative Medical Device Company, Medtronic PLC, Surges in Popularity Among Investors  ~2 min.

Medtronic PLC (MDT) is gaining significant attention from investors due to its groundbreaking medical technology and long-term growth potential....

MDTMarch 21, 2025Medtronic plc MDT: Experts Recommend Buying Stocks for Long-Term Investment  ~1 min.

According to the renowned financial experts at Stocks Prognosis, Medtronic plc (MDT) is one of the best European stocks to buy for long-term investment....



Related news

MDTFebruary 26, 2025MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments  ~2 min.

Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments....

FORDDecember 20, 2024Neuvotion Expands AI-Driven Neurotech Partnership and Secures Investment for NeuStim Launch  ~2 min.

Forward Industries, Inc., through its subsidiary IPS (Intelligent Product Solutions), has announced further expansion of its AI-driven neurotech partnership with Neuvotion....

ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....

FORDDecember 24, 2024FORD FORWARD INDUSTRIES, INC. Announces Exciting Partnership and Launch of Revolutionary Technology for Stroke and Spinal Cord Injury  ~2 min.

Neuvotion, a leading medical device company, has recently expanded its partnership with Intelligent Product Solutions (IPS) and successfully commercialized its innovative NeuStim technology....

ABTDecember 3, 2024Abbott Laboratories Develops New Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a leading global healthcare company, has announced a groundbreaking innovation in medical technology....